Egypt Cancer Diagnostic Market By Product (Consumable v/s Instruments), By Technology (IVD Testing, Imaging, Biopsy), By Application (Breast Cancer, Lung Cancer, Colorectal Cancer, Others), By End User (Hospitals & Clinics, Diagnostic Laboratories, Others

Egypt Cancer Diagnostic Market By Product (Consumable v/s Instruments), By Technology (IVD Testing, Imaging, Biopsy), By Application (Breast Cancer, Lung Cancer, Colorectal Cancer, Others), By End User (Hospitals & Clinics, Diagnostic Laboratories, Others), By Region, Competition, Forecast & Opportunities, 2028

Egypt Cancer Diagnostic Market is anticipated to witness a growth of steady CAGR during the forecast period, 2024-2028. This can be ascribed to the rising prevalence of various chronic diseases such as cancer, cardiovascular diseases, diabetes, and others, the growing number of private diagnostic centers, increasing lifestyle diseases, and increasing rate of rejuvenation and anti-aging amongst the population. Egypt ranks number 2 in the world in terms of deaths caused by cancer, especially liver cancer. According to Global Cancer Observatory (Egypt), in 2020, around 134,632 new cancer cases were reported in the country, in which males and females accounted for 66,542 and 68,090 cases, respectively 2020.

Cancer diagnostics is a method of identifying different biomarkers, proteins, and some signs that lead to the identification of the presence of a cancerous tumor. Efficient diagnostic testing is used to validate or rule out the existence of illness, monitor the progression of the disease, and schedule & review treatment outcomes. Diagnostic procedures for cancer may include imaging, tumor biopsy, laboratory tests (including tests for tumor markers), endoscopic examination, surgery, or genetic testing. However, the demand for new diagnostic techniques/tools is increasing, which is further expected to drive the growth of the Cancer Diagnostic Market.

The growing prevalence of new cancer cases, rising awareness for cancer screening, the advanced technological advancement with the highest accuracy and precision, and the growing awareness for early detection of cancer amongst the population globally are projected to propel the growth of the market. Additionally, expansion in research & development schemes being initiated by various government institutions, private institutions, and diagnostic imaging centers across the globe is further expected to create lucrative opportunities for the growth of the Cancer Diagnostic Market in the coming years. According to the latest report of the World Health Organization, in 2020, liver cancer deaths in Egypt accounted for 24,512 or 4.57% of total deaths.

The growing number of private diagnostic centers

The number of private diagnostic centers is increasing across the country owing to the rising demand for diagnostic imaging procedures as well as a growing burden on public hospitals due to their limited number of imaging modalities. According to recent developments, in 2021, a company, namely Fujifilm DKH LLP, in a joint venture with Dr. Kutty's Healthcare, opened hospitals and screening centers in the Middle East. Due to these centers, cancer can be diagnosed at an early stage and can be treated easily, and patients can recover smoothly.

Rising Rejuvenation and Early-aging in Population

In Egypt, currently, 74% (~75 million) of the population is under the age of 40 years, and it is expected to increase to 86 million by 2030. Concurrently, only 8% (~7.7 million) of the population is over the age of 60 years, which is expected to increase to 13.8% (~18 million) by the end of 2030. However, 4.6 million of the population is above the age of 65 years, which is expected to increase to 12.3 million by 2030. Therefore, there is an increasing demand for services focusing on rejuvenation and anti-aging, including stem cell therapy, hyperbaric oxygen therapy (HBOT), and other similar services.

Sedative Lifestyle Leads to Cancer

Cancer is caused due to an unhealthy lifestyle. Sedentary behaviors have wide-ranging adverse impacts on the human body, including increased all-cause mortality, cardiovascular disease mortality, cancer risk, and risks of metabolic disorders such as diabetes mellitus, hypertension, and dyslipidemia; musculoskeletal disorders such as arthralgia and osteoporosis, depression, etc. For instance, Egypt has one of the highest prevalence of lifestyle diseases in the world, with approximately 17% of the population over 20 years with diabetes, 32% with obesity, and over 25% suffering from hypertension. According to the Centers for Disease Control and Prevention (CDC), around 15% of adults are physically inactive and do not participate in activities such as running, walking for exercise, or gardening. Therefore, a sedentary lifestyle and lack of physical activity can lead to cancer and thereby propel the growth of Egypt Cancer Diagnostic Market.

Growth in Research & Development

Rapid advancements in research and development (R&D) practices and activities are driving the growth of the market on account of the growing need to develop novel diagnostic solutions for the treatment of different life-threatening diseases. According to World Data Atlas (Egypt), in 2020, R&D expenditure for Egypt was 1 %. Therefore, the R&D expenditure of Egypt increased from 0.2 % in 1998 to 1 % in 2020, growing at an average annual rate of 9.82%. A recent advancement also includes cancer treatment with immunotherapy, which is anticipated to be significant to the high availability of immunotherapy drugs, and several initiatives are taken by the government and non-government organizations to make diagnostic procedures affordable. This, in turn, supports the growth of Egypt Cancer Diagnostic Market.

Market Segmentation

Egypt Cancer Diagnostic Market can be segmented on the basis of product, technology, application, end user, region, and company. Based on the product, the market can be further segmented into consumables and instruments. Based on technology, the market is further split into IVD testing, imaging, and biopsy. Based on application, the market is further divided into breast cancer, lung cancer, colorectal cancer, and others. Based on end-user, the market is further segmented into hospitals & clinics, diagnostic laboratories, and others.

Company Profiles

Abbott Egypt, Agilent Egypt, Roche Egypt LLC, FUJIFILM Healthcare Middle East S.A.E., Siemens Healthineers Egypt, BioMerieux Egypt, GE Healthcare Egypt, Ortho Clinical Diagnostics, PerkinElmer International C.V., and Epigenomics Egypt, etc. are some of the key players operating in the Egypt Cancer Diagnostic market.

Report Scope:

In this report, Egypt Cancer Diagnostic Market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

• Cancer Diagnostic Market, By Product:
• Consumable
• Instruments
• Cancer Diagnostic Market, By Technology
• IVD Testing
• Imaging
• Biopsy
• Cancer Diagnostic Market, By Application:
• Breast Cancer
• Lung Cancer
• Colorectal Cancer
• Others
• Cancer Diagnostic Market, By Region:
• Cairo
• Qalyubia
• Alexandria
• Port Said
• Giza
• Suez
• Rest of Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Egypt Cancer Diagnostic Market.

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order. Single User license will be delivered in PDF format without printing rights